Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis

BACKGROUND: Existing data evaluating the impact of metformin on the colorectal adenoma (CRA) risk in patients suffering from type 2 diabetes (T2D) are limited and controversial. We therefore summarized the studies currently available and assessed the relationship between metformin treatment and risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Yi-Chao, Hu, Qiang, Huang, Jiao, Fang, Jing-Yuan, Xiong, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352447/
https://www.ncbi.nlm.nih.gov/pubmed/27903961
http://dx.doi.org/10.18632/oncotarget.13633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352447/
https://www.ncbi.nlm.nih.gov/pubmed/27903961
http://dx.doi.org/10.18632/oncotarget.13633

Ejemplares similares